2-amino-5-phosphono-3-pentenoic-acid and Disease-Models--Animal

2-amino-5-phosphono-3-pentenoic-acid has been researched along with Disease-Models--Animal* in 1 studies

Other Studies

1 other study(ies) available for 2-amino-5-phosphono-3-pentenoic-acid and Disease-Models--Animal

ArticleYear
Diminished amygdala activation and behavioral threat response following traumatic brain injury.
    Experimental neurology, 2016, Volume: 277

    Each year, approximately 3.8 million people suffer mild to moderate traumatic brain injuries (mTBI) that result in an array of neuropsychological symptoms and disorders. Despite these alarming statistics, the neurological bases of these persistent, debilitating neuropsychological symptoms are currently poorly understood. In this study we examined the effects of mTBI on the amygdala, a brain structure known to be critically involved in the processing of emotional stimuli. Seven days after lateral fluid percussion injury (LFPI), mice underwent a series of physiological and behavioral experiments to assess amygdala function. Brain-injured mice exhibited a decreased threat response in a cued fear conditioning paradigm, congruent with a decrease in amygdala excitability determined with basolateral amygdala (BLA) field excitatory post-synaptic potentials together with voltage-sensitive dye imaging (VSD). Furthermore, beyond exposing a general decrease in the excitability of the primary input of the amygdala, the lateral amygdala (LA), VSD also revealed a decrease in the relative strength or activation of internuclear amygdala circuit projections after LFPI. Thus, not only does activation of the LA require increased stimulation, but the proportion of this activation that is propagated to the primary output of the amygdala, the central amygdala, is also diminished following LFPI. Intracellular recordings revealed no changes in the intrinsic properties of BLA pyramidal neurons after LFPI. This data suggests that mild to moderate TBI has prominent effects on amygdala function and provides a potential neurological substrate for many of the neuropsychological symptoms suffered by TBI patients.

    Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Amygdala; Animals; Brain Injuries; Brain Mapping; Conditioning, Psychological; Cues; Disease Models, Animal; Electric Stimulation; Escape Reaction; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Fear; Male; Mice; Mice, Inbred C57BL; Sodium Channel Blockers; Tetrodotoxin; Voltage-Sensitive Dye Imaging

2016